ENDRA Life Sciences Inc. — Director's Dealing 2019

May 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2019-05-28

Reporting Person: Maloberti Renaud Bertrand (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-28	Stock Options	$1.04	A	35000	Acquired	2029-05-28	Common Stock (35000)	Direct

Footnotes

F1: These Stock Options become exercisable in three equal annual installments beginning on May 28, 2020.